Although nuclear factor-jB (NF-jB) usually exerts anti-apoptotic activity, upon activation by interleukin-1 (IL-1) it enhances ultraviolet-B radiation (UVB)-induced apoptosis. This paradoxical effect is associated with NF-jB-dependent pronounced secretion of tumour necrosis factor-a (TNF) which activates TNF-R1 in an autocrine fashion to enhance UVB-induced apoptosis. We demonstrate that sustained TNF transcription in UVB þ IL-1-treated cells involves complete abrogation of the negative feedback loop of NF-jB preventing IjBa resynthesis, hence allowing uncontrolled NF-jB activity. We show that IjBa is not transcriptionally inhibited but resynthesized protein is immediately marked for degradation due to persistent inhibitor of jB kinaseb (IKKb) activity. Continuous IKKb phosphorylation and activation is caused by UVB-mediated inhibition of the phosphatase PP2A. This study demonstrates that the cellular response to different NF-jB activators may be converted to the opposite reaction when both stimuli act in concert. Our data shed new light on the significance of negative feedback regulation of NF-jB and identifies PP2A as the key regulator of this process. The transcription factor nuclear factor-kB (NF-kB) is involved in many cellular responses. It comprises five proteins: p50/ p105, p52/p100, p65, c-Rel and RelB that exist as homo-and heterodimers, p65/p50 being the most abundant form. In unstimulated cells, NF-kB is sequestered in the cytoplasm through interaction with the inhibitory protein IkBa that masks its nuclear localization signal.
The transcription factor nuclear factor-kB (NF-kB) is involved in many cellular responses. It comprises five proteins: p50/ p105, p52/p100, p65, c-Rel and RelB that exist as homo-and heterodimers, p65/p50 being the most abundant form. In unstimulated cells, NF-kB is sequestered in the cytoplasm through interaction with the inhibitory protein IkBa that masks its nuclear localization signal.
1 NF-kB (p65/p50) is mostly activated by pro-inflammatory mediators, including tumour necrosis factor-a (TNF), interleukin-1 (IL-1) or LPS. Activated receptors mediate activation of a multi subunit inhibitor of kB kinase (IKK) complex consisting of IKKa, -b and -g. Activated IKK acts through phosphorylation of IKKb at Ser177/181, subsequently catalysing phosphorylation of inhibitor of kBa (IkBa) at Ser32/36, leading to its polyubiquitination and proteasomal degradation. Released NF-kB translocates into the nucleus to activate responsive genes, among these the one encoding IkBa. 2 Nuclear export of resynthesized IkBa is more potent than import, allowing cytosolic localization of the inactive complex, thus creating a negative feedback loop. 3 As NF-kB serves many different functions, tight regulation by the negative feedback loop is crucial. Only highly controlled and transient expression of NF-kB-driven genes ensures proper function. Uncontrolled NF-kB activity is linked to transformation, proliferation, suppression of apoptosis and metastasis. 4, 5 Thus, strategies interfering with signalling pathways activating NF-kB have become major targets for anticancer interventions. 6 We have previously shown that stimulus-dependent activation of NF-kB can result in completely opposite effects. Stimulation with IL-1 protects keratinocytes and epithelial cells from cytotoxic effects of death ligands in an NF-kB-dependent manner by upregulation of anti-apoptotic cFLIP and cIAPs. 7 In contrast, stimulation with IL-1 and ultraviolet-B light (UVB) resulted in NF-kB-dependent downregulation of anti-apoptotic genes and simultaneous upregulation of pro-apoptotic TNF. Both events act in concert to enhance the predominantly intrinsic pathway triggered by UVB through additional activation of the extrinsic pathway by TNF-R1. 8 NF-kB-dependent repression of anti-apoptotic genes in response to DNAdamaging agents was shown to be facilitated by p14 ARFinduced association of p65 with the gene silencer histone deacetylase-1 (HDAC1) at different promoters, 9 turning NF-kB into a repressor of anti-apoptotic genes by ARF-induced ATR-and CHK1-dependent phosphorylation of p65. 10, 11 One proposed mechanism is that UVB drives the proapoptotic effect of NF-kB by general repression of antiapoptotic genes. However, additional mechanisms exist, as NF-kB upon IL-1 þ UVB co-treatment significantly enhances TNF expression compared to IL-1 alone. Although a mechanism underlying UV-mediated repression of NF-kB-regulated genes has been proposed, the mechanism by which UVB accelerates NF-kB-dependent TNF transcription remains unclear. Here we show that activation of TNF gene by UVB in IL-1-treated cells relies on complete inhibition of the negative feedback loop involving IkBa resynthesis, hence allowing uncontrolled NF-kB activity. Lack of IkBa production is not transcriptionally regulated but caused by persisting IKKb activity, allowing continuous degradation of de novo synthesized IkBa. Enhanced activity of IKKb is caused by UVB-mediated inhibition of phosphatase PP2A, a potential negative regulator of IKKb. 12 This study identifies UVB to directly affect the negative feedback loop thereby changing the physiological properties of NF-kB. It also demonstrates that biologic effects induced by different NF-kB activators may tremendously differ when both act in concert.
Results
Co-stimulation with IL-1 inhibits TRAIL-but enhances UVB-induced apoptosis by NF-jB activation. Utilizing the epithelial cell line KB, co-stimulation with IL-1 was shown to desensitize cells from death receptor-induced apoptosis, whereas UVB-induced apoptosis was significantly enhanced due to NF-kB-dependent TNF production and downregulation of anti-apoptotic genes. 8 EMSA revealed that differential NF-kB responses (Figure 1a and c) were neither due to changes in intensity of activation nor to activation of alternative NF-kB activating pathways or to differences in heterodimer composition (Figure 1b) . Accordingly, investigating the molecular mechanism underlying these differential cellular responses to NF-kB p50/p65 is of particular interest.
IL-1 enhances UVB-induced apoptosis by autocrine TNF-TNF-R1 signalling. Semiquantitative PCR analysis confirmed that enhanced TNF secretion upon IL-1 þ UVB stimulation (Figure 1c ) relies on sustained and elevated TNF transcription resulting in accumulation of TNF protein in supernatants over time, finally allowing autocrine TNF-R1 activation resulting in additive apoptotic signalling (Figure 2a) .
TNF-R1-mediated apoptosis but not NF-kB-dependent, non-apoptotic responses depends on internalization of the receptor signalling complex. 13, 14 Accordingly, FACS analysis revealed a non-apoptotic TNF dose (5 ng/ml) to not result in detectable loss of membrane TNF-R1 staining, whereas an apoptotic dose (100 ng/ml) caused a marked decrease of membrane TNF-R1 expression after 2 h, indicative of receptor internalization and induction of apoptotic pathways (Figure 2b ). Thus, TNF-R1 internalization should precede IL-1 þ UVB-induced induction of autocrine TNF-mediated apoptosis. UVB exposure alone produced a slow and only partial reduction in TNF-R1 membrane levels, whereas IL-1 þ UVB caused a rapid loss of TNF-R1 at 2 h, which further decreased after 4 h (Figure 2b ). Confirming the critical role of autocrine TNF signalling, IL-1-mediated enhancement of UVB-induced apoptosis was blocked with an antagonistic TNF-R1 antibody 15 ( Figure 2c ). Data show that enhancement of TNF secretion is largely regulated by persistent transcription of TNF gene, suggesting sustained NF-kB activation.
Inhibition of IjBa reappearance is responsible for sustained NF-jB activity and elevated TNF production. IL-1 stimulation typically results in early, but transient NF-kB activation with maximum degradation of IkBa between 15 and 30 min. Rapid transcriptional activation of the IkBa gene and resynthesis of the protein result in replenishment of cytosolic IkBa after 1-2 h, finally terminating NF-kB activity. 3 This kinetics applies for KB cells upon co-treatment with IL-1 and TRAIL (Figure 3a) . In contrast, co-stimulation with IL-1 þ UVB completely abrogated reappearance of IkBa protein in the cytoplasm for at least 4 h (Figure 3a) . At this time point cells are irreversibly committed to undergo apoptosis (data not shown). Correspondingly, EMSA revealed that high NF-kB levels persisted in the nucleus upon IL-1 þ UVB co-treatment for several hours, whereas upon IL-1 treatment, NF-kB vanished from the nucleus with kinetics matching reappearance of IkBa in the cytoplasm (Figures 3a  and b ). This suggests that prolonged production of TNF is regulated at the level of IkBa turnover. Therefore, we mimicked inhibition of IkBa resynthesis by pre-incubation of cells with cycloheximide (CHX). At a concentration higher than 1 mg/ml, CHX completely inhibited IkBa de novo protein synthesis after 2 h (Figure 3c ), when IkBa resynthesis is usually completed (Figure 3a) . CHX-mediated inhibition of IkBa recurrence caused elevated TNF transcription in IL-1-treated cells even 4 h after stimulation. At this time point TNF transcription had almost ceased in the absence of CHX (Figure 3d ) due to IkBa resynthesis and termination of NF-kB activity. These results support that inhibition of the negative feedback loop drives NF-kB-dependent TNF production.
Inhibition of IjBa reappearance is due to its immediate post-translational proteasomal degradation. As NF-kB can change from an activator to a repressor for selected genes, 8 loss of IkBa reappearance might be regulated at the transcriptional level. However, IL-1-mediated transcription pattern of IkBa remained unchanged upon co-stimulation with UVB (Figure 4a ), suggesting that inhibition of IkBa reappearance is regulated post-transcriptionally, affecting either translation or protein stability.
Once designated by IKKb-mediated phosphorylation IkBa is proteasomally degraded. Addition of proteasome inhibitor MG132 1 h before IL-1 or IL-1 þ UVB stimulation prevented initial IkBa degradation. Adding MG132 15 min after stimulation and initial IkBa degradation, resynthesized IkBa reappeared within the cytoplasm (Figure 4b ), indicating that translation was not impaired. Thus, failure to accumulate a critical level of IkBa sufficient to limit NF-kB activity appears to result from immediate and continuous proteasomal degradation of newly synthesized protein. To scrutinize whether immediate IkBa degradation follows conserved patterns or is due to any alternative mechanism the Ser32/36 phosphorylation status of newly synthesized IkBa captured in the cytoplasm by MG132 application was analysed. Corresponding to initial stimulation, resynthesized IkBa was phosphorylated at Ser32/36 marking it for degradation and causing sustained NF-kB activation (Figure 4c ).
Assessing the role of IKKb in continuous IkBa degradation, blocking its activity by the selective inhibitor BAY-11-7082 resulted in reappearance of IkBa in IL-1 þ UVB-treated cells (Figure 4d ), strongly suggesting constitutive IKKb activation to be responsible for controlling IkBa reappearance. As IKKb requires phosphorylation at Ser177/181 for activation, 2 we monitored IKKb phosphorylation status (Figure 4e ). Initial IkBa degradation coincided with strong IKKb Ser177/181 phosphorylation, irrespective of co-stimulation with UVB, indicating IL-1 to be the predominant trigger. IKKb phosphorylation stayed stable for up to 1 h. After 2 h of IL-1 stimulation, IKKb phosphorylation had completely vanished allowing stabilization of resynthesized IkBa. In contrast, IKKb remained phosphorylated in cells co-stimulated with IL-1 þ UVB after 2 h, preventing IkBa resynthesis. In vitro kinase assay with IKKb immunoprecipitated from cells 2 h after co-stimulation with IL-1 þ UVB, using a purified IkBa(5-55) fragment confirmed high IKKb activity at this time point (Figure 4f ). Together, these data demonstrate that phosphorylation of resynthesized IkBa upon stimulation with IL-1 þ UVB for 2 h is a direct downstream effect of continuous IKKb phosphorylation and activity.
Cooperation of IL-1 and UVB signalling is a prerequisite for enhanced apoptosis. Inhibition of IkBa reappearance seems to be the molecular trigger efficiently enhancing UVB-induced apoptosis. As UV may induce NF-kB activation itself, 3, 16 prolonged activation might result from additive IkBa degradation following the transient IL-1 signal. Investigating the kinetics of IkBa degradation and NF-kB activity at 300 J/m 2 UVB used in this study, UVB alone caused a rather weak and delayed NF-kB response after 10-16 h, coinciding with only partial IkBa degradation ( Figure 5a ). However, at 2 h neither IkBa degradation nor NF-kB translocation into the nucleus was detected, suggesting cooperative signalling.
Hence, we investigated the time window of cooperative signalling required to convert IL-1 signalling to pro-apoptosis by UVB. Cells pre-exposed for various length of time (15 min to 8 h) to IL-1 were irradiated with UVB. Alternatively, IL-1 was added after irradiation for identical time intervals (15 min to 8 h) and apoptosis measured 16 h following UVB. IL-1-mediated enhancement of apoptosis was recorded in a narrow window around UVB treatment, ranging from 30 min before to 1 h after irradiation ( Figure 5b , upper panel) and coincided with pronounced TNF release ( Figure 5b , lower panel). This confirms the close interrelationship between TNF production and IL-1-mediated acceleration of UVB-induced apoptosis, revealing critical temporal constraints of cooperative signalling.
To translate tight co-stimulation to interference with IkBa reappearance, cells were stimulated with IL-1 and harvested after 2 h, when cytosolic IkBa levels have regained pre- Figure 1 Interleukin-1 (IL-1) causes activation of the p65/p50 irrespective of the apoptotic co-stimulus. IL-1-induced enhancement of ultraviolet-B light (UVB)-induced apoptosis coincides with tumour necrosis factor-a (TNF) production. Cells were stimulated with IL-1, UVB, TRAIL, or co-stimulated with IL-1 and any of the apoptotic stimuli. (a) After 16 h apoptosis was determined in a cell death detection (CDD). (b) After identical stimulation for 30 min nuclear translocation of nuclear factor-kB (NF-kB) was analysed by EMSA and heterodimer composition in a supershift assay using antibodies against p65, p50, p52, cRel and RelB. ns, non-stimulated cells; *, UVB irradiation alone. (c) TNF in supernatants of cells analysed in (a) was determined in a TNF ELISA stimulation levels. In addition, cells were UVB irradiated in intervals from 5 min up to 120 min prior to harvest (Figure 5c ). WB analysis revealed that IkBa reappearance was only inhibited when the time span between IL-1 and UVB stimulation did not exceed 30 min, closely matching the temporal constraints for TNF production and apoptosis (Figure 5b ).
UVB-induced inhibition of PP2A is responsible for persistent IKKb activity. We next examined how IKKb phosphorylation is maintained in IL-1 þ UVB co-treated cells. Screening for IKKb upstream targets that might become either activated or inhibited by UVB, thereby causing chronic IKKb phosphorylation, revealed that chemical inhibition or siRNA knockdown of potential IKKb activators (in particular TAB1/TAK, JNK, RIP1, MAPK, AKT, PKD, PKCd, PI3K, CK II, DNA-PK (including ATM and ATR) IKKg and p38) as well as ROS scavenging (PDTC, GSH, NAC, Trolox), IKKg Ser85Ala mutation and overexpression of inhibitors CYLD and A20 all failed to allow IkBa reappearance in IL-1 þ UVBtreated cells (see Supplementary Figure S1 ).
Therefore it seemed that IL-1 þ UVB cooperate to maintain IKKb activity by inhibiting its dephosphorylation. So far inactivation 12 as well as activation 17 of IKKb have been described to be mediated by the Ser/Thr-phosphatase PP2A in vitro. PP2A is a multi-subunit protein with PP2Ac being the catalytic subunit. Indeed, co-immunoprecipitation revealed that endogenous PP2Ac was constitutively associated with IKKb, proposing a functional relationship (Figure 6a ). To elucidate the role of PP2A as a potential negative regulator of IKKb and to mimic the assumed UVB-mediated inactivation, the effect on IkBa degradation in IL-1-treated cells was studied upon specific inhibition of PP2Ac by calyculin A and/or siRNA-mediated knockdown. The results fully confirm the critical role of PP2A as a negative regulator of IKKb. Each, knockdown of PP2Ac and specific inhibition resulted in persistent IKKb phosphorylation and IkBa degradation upon IL-1 stimulation, with combined treatment producing the strongest effect (Figure 6b ). In vitro kinase assay with PP2Ac knockdown cells confirmed that IKKb in IL-1-treated cells induced a persistent IkBa phosphorylation (Figure 6c) . Furthermore, knockdown of PP2Ac allowed a sustained TNF production at the mRNA and the protein level (Figures 6d and e) , supporting the functional relationship between cooperative inhibition of PP2Ac and TNF production finally leading to enhancement of apoptosis.
Finally, we investigated the effect of UVB on PP2Ac activity. Ex vivo irradiation of whole-cell lysates with UVB followed by an in vitro phosphatase assay with a threonine phosphopeptide revealed overall phosphatase activity to be reduced to approximately 80% of untreated controls (Figure 6f ). Phosphatase activity of PP2Ac immunoprecipitated from UVBexposed cells was found to be strongly reduced to about 35% of the activity in control cells, supporting the concept that continuous IKKb phosphorylation and subsequent IkBa degradation in IL-1 þ UVB-treated cells is a result of PP2Ac inhibition. Conclusively, our data reveal two major findings: First they identify PP2Ac to be a novel cellular target of UVB and second they unravel chronic NF-kB activation to be involved in cell killing instead of cell survival. Consequently, combination of PP2Ac inhibition and DNA-damaging chemotherapeutic drugs may have broader implications in cancer therapy.
Discussion
UVB radiation may serve as a carcinogen by activation of skin oncogenes or inactivation of tumour suppressors and by repression of cell-based immune responses that are generally able to eliminate highly antigenic skin tumours. 18 In contrast, UVB-induced DNA damage is a prerequisite for execution of apoptosis, leading to elimination of cancer-prone cells, thereby protecting the skin from keratinocyte transformation. 19, 20 The molecular switch, however, has not yet been identified. It has long been known that human keratinocytes are a potent source of IL-1 21 that becomes activated and released in response to UVB. 22, 23 In this respect keratinocytes serve an important role in the induction of skin immune responses under physiological and pathological conditions like sunburn and other inflammatory skin diseases. 22, 24 According to our findings, UVB-induced apoptosis of keratinocytes and epithelial cells is significantly enhanced upon co-treatment with IL-1 in vitro. 7, 8, 25 Correspondingly, UVB-induced apoptosis of keratinocytes in vivo may be facilitated by concomitant IL-1 signals from neighbouring cells. We therefore propose that the signal cross talk at the level of keratinocytes is of patho/ physiological relevance in differential skin responses to UVB.
In this study we shed light on the molecular mechanism underlying the paradoxical finding that IL-1-mediated NF-kB activation causes acceleration of UVB-induced apoptosis. Our findings account for sustained transcriptional upregulation of TNF to be a prerequisite for TNF secretion and autocrine activation of TNF-R1 to additively enhance UVBinduced apoptosis, corroborating previous findings. 7, 8 Opposing effects of TNF coincide with compartmentalization of activated TNF-R1 complexes.
13,14 TNF-R1 mediates a pro-apoptotic response only after internalization of the complex, whereas membrane-anchored TNF-R1 generates NF-kB activation.
14 The observed TNF-R1 internalization upon IL-1 þ UVB treatment is in full accordance with a predominating apoptotic response initiated by autocrine TNF. UVB alone also induced TNF-R1 internalization, however with a different kinetics and to a lesser extent, which might result from the ability of UV to induce ligandindependent activation of death receptors. 26, 27 We show that initial IL-1-governed degradation of IkBa is required for NF-kB activation. Upon co-stimulation with UVB slowly increasing amounts of resynthesized IkBa protein continuously become degraded due to constitutive IKKb phosphorylation caused by UVB-induced inhibition of its negative regulator PP2Ac. Through this mechanism the negative feedback loop for NF-kB is abolished resulting in sustained NF-kB activation. Under these specific conditions NF-kB persists to upregulate TNF and to repress antiapoptotic genes finally producing pro-apoptotic effects (Figures 7a and b) .
As TNF is not a strong inducer of apoptosis but of NF-kBmediated survival signals in epithelial cell lines, downregulation of anti-apoptotic proteins (FLIP, cIAP) and signal transducers (TRAF 1, -2, -6) complement to trigger apoptotic pathways under the given conditions. 8 Our findings account for selective transcriptional upregulation of TNF as a prerequisite for TNF secretion and autocrine TNF-R1 activation.
NF-kB activity could escape termination upon IL-1 þ UVB stimulation due to lack of IkBa resynthesis. The IkBa gene itself is regulated by NF-kB and post-degradational de novo synthesis of IkBa serves as a negative feedback regulation terminating NF-kB. 28 Consequently, failure of IkBa resynthesis coincided with prolonged nuclear localization of NF-kB. Sustained NF-kB activity seems to account for elevated TNF transcription, as inhibition of IkBa protein synthesis with CHX after initial degradation resulted in increased TNF mRNA expression upon IL-1 stimulation.
Unlike the TNF transcription pattern, the IL-1-dependent IkBa transcription profile remained unchanged in UVBirradiated cells. Peculiarly, immediate post-translational degradation of resynthesized IkBa was found to cause lack of its cytosolic reappearance. UVC and UVB alone can induce NF-kB activation, but no common mechanism became apparent. IKK and IkBa degradation-dependent and -independent mechanisms have been described and the time courses vary remarkably. 16, 28, 29 In our hands, UVB-alonetriggered NF-kB activation only strongly delayed and was accompanied by only partial degradation of IkBa, excluding the effect of IL-1 þ UVB-mediated instability of resynthesized IkBa to be just additive.
Our kinetic studies identified a critical time window (30 min before until 1 h after UVB) of co-stimulation to be essential for the enhancing effect of IL-1 on UVB-induced TNF secretion and apoptosis. Identical kinetics applied for IkBa degradation, revealing that the temporal constraints of this cooperative signalling affect IkBa protein levels.
HDAC inhibitor trichostatin A was reported to potentiate TNF-mediated activation of several NF-kB-driven genes, being associated with delayed reappearance of IkBa and prolonged IKK activity. 30 Enhanced proteasomal degradation of IkBa in our setting also appeared to be linked to signals upstream of its phosphorylation, because it could be counteracted by inhibition of IKKb. Correspondingly, resynthesized IkBa captured by proteasome inhibition after IL-1 þ UVB treatment displayed phosphorylation of Ser32/36 residues. This implied that IkBa degradation was not due to alternative, possibly UVB-induced, cleavage of IkBa, and was consolidated by the observation that stability of IkBa Ser32/36Ala mutants remained unaffected by IL-1 þ UVB (Supplementary Figure S2) . Kinetic analysis finally revealed that IKKb dephosphorylation at Ser177/181 in IL-1-treated cells fully matched reappearance of IkBa in the cytoplasm after 2 h. In contrast, IKKb remained phosphorylated in cells treated with IL-1 þ UVB, thereby preventing IkBa resynthesis.
Data allowed two interpretations: either UVB activates an upstream kinase that constitutively phosphorylates IKKb or it inactivates a phosphatase, thereby preventing its dephosphorylation. PP2A is known to modulate NF-kB activity, 31 its precise role in NF-kB-dependent cellular responses, however, remains controversial. Although IKK-PP2A complex formation was suggested to be required for TNF-induced IKKb phosphorylation and IkBa degradation, 17 more evidence exists connecting inhibition of PP2A to NF-kB activation: PP2A inhibition with calyculin A or ocadaic acid both resulted in IkBa phosphorylation and proteasomal degradation without additional cytokine treatment. 32, 33 Correspondingly, ocadaic acid treatment of monocytes caused IL-1 production linking PP2A inhibition to NF-kB-dependent responses. 34 Moreover, PP2A was shown to interact with IKKg to downregulate activation of IKKb following TNF treatment. 35, 36 We show that the catalytic subunit PP2Ac associates with IKKb. Furthermore, siRNA-mediated knockdown of PP2Ac and specific inhibition by calyculin A resulted in degradation of IkBa 2 h after IL-1 stimulation in vivo and in vitro, in both cases coinciding with chronic IKKb phosphorylation, mimicking the cellular response to IL-1 þ UVB. Stimulus-dependent recruitment of PP2A to IKK can be ruled out, as endogenous PP2Ac co-precipitated with IKKb even in unstimulated cells. But, irradiation of cell lysates with UVB reduced total cellular phosphatase activity by B20%, indicating that UVB generally affects phosphatase activity. However, the majority of phosphatases remained unaffected, provided by the fact that the substrate used was not PP2A specific, but can be processed by other phosphatases present in cell lysates. Yet, immunoprecipitated PP2Ac proved to be particularly sensitive to UVB, resulting in B65% inhibition of its catalytic activity.
Suppression of PP2A was shown to cooperate with oncogenic changes to promote cell transformation. 37 Suppression of PP2A in IL-1-treated cells presumably could also result in tumour progression due to constitutive NF-kB activation. In combination with UVB, however, NF-kB promotes pro-apoptotic pathways and may exert completely different effects on tumour growth. In conclusion, the present study attributes a crucial role to PP2A in maintaining the negative feedback loop terminating NF-kB. In addition, we unravel a novel mechanism by which persistent NF-kB activation plays an unexpected role as a pro-apoptotic mediator and is a vivid example for the importance of signalling contexts for overall cellular responses.
Because of NF-kB's crucial role in physiology and pathophysiology, NF-kB-activating pathways are in the focus of therapeutic interventions. 38 Combinations of targeted therapies with radio-and chemotherapeutics are in progress to advance the treatment of cancer and inflammatory diseases. 38, 39 Therefore, an integrated understanding of cellular responses to NF-kB appears mandatory. This requires knowledge about the context-dependent behaviour of NF-kBtriggered signalling pathways and molecules to pinpoint suitable targets, like PP2Ac, to improve therapeutic strategies. In parallel cells were mock treated or irradiated with UVB and PP2Ac was immunoprecipitated. Lysates and precipitates were subjected to an in vitro phosphatase assay using a threonine phosphopeptide as a substrate medium with 2% FCS. UVB irradiation (300 J/m 2 ) was performed with TL12 fluorescent bulbs (290-320 nm; Philips). Apoptosis was triggered with 80 ng/ml lz-TRAIL. 40 Recombinant human IL-1b (R&D Systems) was applied at 10 ng/ml. Transfection of cells with siRNA (MWG) was carried out in Lipofectamin2000 (Invitrogen). For semiquantitative RT-PCR, cDNA was generated as described before 25 using the RedTaq system (Sigma). Proteasome inhibition was achieved with MG132 (25 mM; Merck). IKKb-inhibitor BAY-11-7082 was applied at 30 mM (Merck). PP2Ac inhibitor calyculin A (Cell Signaling) was added at 5 nM. TNF was measured with a TNF ELISA (BioSource), apoptosis with a Cell Death Detection (CDD)-ELISA (Roche). The enrichment of nucleosomes released into the cytoplasm by factor 2 corresponds to 10% apoptotic cells as determined by AnnexinV FACS analysis.
EMSA and supershift analysis. Following stimulation cells were harvested and nuclear extracts were generated as described before. 25 EMSA was performed using an NF-kB consensus oligonucleotide (sc-2505; Santa Cruz). For supershift assays the following antibodies recognizing p65, p50, p52, c-Rel and RelB were used: sc-109X, sc-7178X, sc-7386, sc-70X, sc-226X (Santa Cruz).
Immunoprecipitation, WB analysis and in vitro kinase assay. Cells were lysed in lysis buffer (50 mM HEPES, pH 7.5; 150 mM NaCl; 10% glycerol; 1% Triton X-100; 1.5 mM MgCl 2 ; 1 mM EGTA; 100 mM NaF; 10 mM pyrophosphate, 0.01% NaN 3 and Complete s protease inhibitor cocktail (Roche) for 15 min on ice. Endogenous PP2Ac was immunoprecipitated using a specific antibody (no. 05-421, clone 1D6; Upstate) and A/G-plus agarose (Santa Cruz) overnight. Precipitates were analysed by WB using antibodies against PP2Ac and IKKb (10A9B6; Imgenex). For WB analysis cytosolic and nuclear protein extracts were detected with antibodies against IkB-a, P-IkBa-Ser32/36, P-IKKb-Ser177/181, PP2Ac (L35A5, 5A5, 16A6, no. 2038; Cell Signaling), IKKb (10A9B6; Imgenex) and a-tubulin (DM1A; Neomarkers). For kinase assay immunoprecipitation of IKKb-YFP was carried out as above. GST-IkBa (5-55) was purified with GSH-sepharose-4B (Amersham) and incubated with IKKb and [ 32 P]-g-ATP in kinase buffer and analysed by SDS-PAGE and autoradiography.
FACS analysis. To monitor membrane-bound TNF-R1, FACS analysis was performed as described before 25 using 1 mg of anti-TNFa T1 mouse IgG1 (H398) per 2 Â 10 5 cells and an goat anti-mouse IgG conjugated to Phycoerythrin (Santa Cruz). Cells were analysed in FACSCalibur Flow Cytometer (Becton Dickinson) and using WinMDI 2.8 software.
Phosphatase assay. Cell lysates (10 mg) or immunoprecipitated PP2Ac were diluted in 74 ml phosphatase assay buffer (50 mM Tris-HCl, pH 7.0; 100 mM CaCl 2 ) and incubated with 6 ml threonine phosphopeptide (final concentration 75 mM) for 5 min at 30 1C. Malachite green solution (20 ml) (BioAssay Systems) was added and absorption measured at different time points at 650 nm. Phosphatase activity of unirradiated cells was determined to be 100%. As an assay standard a serial dilution of 40 mM phosphate (BioAssay Systems) was used. 
